Market Size (2025)
$173.55M
Vertical: CNMBase Year: 2025
Market Size (2025)
$173.55M
Projected (2032)
$332.07M
CAGR (2022–2032)
9.8%
Key Players
11+
Market Overview
The Global Ascophyllum Nodosum Extract Market was valued at USD 173.55 Million in 2025 and is projected to reach USD 332.07 Million by 2032, expanding at a CAGR of 9.70% during 2026–2032. Over 2025–2032 the market is expected to add USD 158.53 Million in absolute value, up from USD 130.89 Million in 2022. The market comprises extracts of the brown seaweed Ascophyllum nodosum (rockweed or knotted wrack), harvested from the intertidal zone of the North Atlantic and processed into liquid concentrates and soluble powders and flakes that are applied to crops as plant biostimulants.
Growth is underpinned by the formal recognition of plant biostimulants in fertiliser legislation in the European Union and India, by rising grower exposure to drought, heat and salinity stress, and by policy and cost pressures to improve nutrient-use efficiency. Ascophyllum nodosum is the most widely studied seaweed species in agricultural use, and suppliers are increasingly positioning extracts around specific, trial-backed claims such as abiotic-stress tolerance and nitrogen-use efficiency rather than general plant vigour.
Key Findings
Physical form: Liquid is the largest form with a 65.0% share in 2025 (USD 112.81 Million) and is also the fastest-growing form at a CAGR of 10.36%.
Crop type: Fruits & Vegetables is the largest crop segment with a 50.0% share in 2025, while Cereals & Grains is the fastest-growing segment at a CAGR of 10.96%.
Application method: Foliar application leads with a 60.0% share in 2025; Seed Treatment is the fastest-growing method at a CAGR of 12.22%.
Region: Europe is the leading region, valued at USD 64.21 Million in 2025 (37.0% share). Asia Pacific is the fastest-growing region at a CAGR of 11.22%.
Country: The U.S. is the largest country market at USD 27.07 Million in 2025, while India is the fastest-growing country at a CAGR of 13.51%.
Segmentation Summary
By physical form, liquid extracts dominate because they are easy to tank-mix with foliar nutrition and crop-protection programmes and to inject through fertigation systems; liquid is valued at USD 112.81 Million in 2025 and is forecast to reach USD 225.15 Million by 2032 (CAGR 10.36%). Powder & flakes, valued at USD 60.74 Million in 2025, remain important for long-distance export, dry blending and price-sensitive markets, and grow at 8.39%.
By crop type, fruits & vegetables account for half of 2025 demand (USD 86.77 Million), reflecting high crop value per hectare and the importance of fruit set, size and shelf life. Cereals & grains (USD 43.39 Million in 2025) are the fastest-growing crop segment at 10.96%, as seed treatments and fertiliser coatings make extract use economical on broadacre crops. Turf & ornamentals and others follow with 15.0% and 10.0% shares, respectively.
By application method, foliar application represents 60.0% of the market in 2025 (USD 104.13 Million). Soil application holds 30.0%, and seed treatment, although the smallest method at USD 17.35 Million in 2025, is projected to grow fastest at 12.22% and more than double to USD 39.02 Million by 2032.
By region, Europe leads with USD 64.21 Million in 2025, supported by its long-established seaweed processing base and the EU Fertilising Products Regulation. Asia Pacific (USD 38.18 Million) and North America (USD 34.71 Million) follow, while Latin America (USD 27.77 Million) and Middle East & Africa (USD 8.68 Million) are smaller but growing above the global average.
Competitive Landscape Summary
The market is moderately consolidated at the raw-material and extraction stage and fragmented at the formulation and distribution stage. A limited number of vertically integrated companies control licensed Ascophyllum harvesting areas and extraction capacity in Canada, the United States, Ireland, the United Kingdom, Norway and France. Acadian Plant Health (Acadian Seaplants), Syngenta Biologicals (through Valagro and its Norwegian harvesting subsidiary Algea) and UPL (through Laboratoires Goëmar) are the leading suppliers. Rovensa Next, Yara and Huber AgroSolutions are significant challengers, and specialists such as Brandon Bioscience, BioAtlantis, North American Kelp, Kelpinor and Seasol International compete in defined niches. Competition centres on secure seaweed supply, proprietary extraction processes, claim-specific registrations under the EU Fertilising Products Regulation, and access to global distribution through alliances with agrochemical and fertiliser companies.
Challenges and Opportunities
The main challenge is raw-material supply. Ascophyllum nodosum is predominantly wild-harvested, regrows slowly and is subject to harvest leases, cutting-height rules and biomass caps; new harvesting licences in Ireland have met local opposition. Other challenges include variable field performance across products, the cost of generating efficacy data for registration, and competition from lower-cost seaweed species and other biostimulant categories. Key opportunities lie in seed treatment and fertiliser-coating applications, in broadacre cereal and grain crops, in the faster-growing markets of Asia Pacific and Latin America, and in claim-specific products for drought, heat and salinity stress.
Future Outlook
The market is expected to nearly double between 2025 and 2032, rising from USD 173.55 Million to USD 332.07 Million. Growth will increasingly come from emerging agricultural economies, with Asia Pacific's share rising from 22.0% in 2025 to 24.2% in 2032, and from application methods that use extracts more efficiently per hectare. Suppliers that secure sustainable seaweed volumes, document crop-specific efficacy and expand through distribution partnerships are best positioned to capture this growth.
The Ascophyllum Nodosum Extract Market market is projected to grow at a CAGR of 9.8% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Ascophyllum nodosum is a perennial brown alga (class Phaeophyceae, order Fucales) that grows in the rocky intertidal zone of the North Atlantic, with commercially harvested stands in Atlantic Canada, the north-eastern United States, Ireland, Scotland, Norway, Iceland and France. Ascophyllum nodosum extract is the product obtained by processing harvested fronds through alkaline hydrolysis, neutral or acidic aqueous extraction, cold-process or enzymatic extraction, or physical methods such as high-pressure cell disruption. The resulting extract contains a complex of bioactive compounds, including alginates, laminarin, fucoidan, mannitol, phlorotannins, betaines, amino acids, minerals and trace quantities of plant-hormone-like substances.
For the purpose of this study, the market covers Ascophyllum nodosum extracts used in agriculture and horticulture as plant biostimulants or as functional components of fertiliser products, supplied in liquid form or as soluble powder and flakes, and applied to the foliage, to the soil (including fertigation and drip irrigation) or to seed.
Included:
Liquid seaweed concentrates and soluble extract powders and flakes produced from Ascophyllum nodosum.
Formulated biostimulant products in which Ascophyllum nodosum extract is the principal active component, including blends with nutrients, micronutrients or humic substances.
Products used on fruits and vegetables, cereals and grains, turf and ornamentals, and other crops such as oilseeds, pulses, plantation and industrial crops.
Excluded:
Extracts of other seaweed species such as Ecklonia maxima, Kappaphycus alvarezii, Sargassum spp., Laminaria spp. and Durvillaea spp., except where Ascophyllum nodosum is a declared component.
Unprocessed seaweed meal used as animal feed or as a bulk soil amendment.
Ascophyllum nodosum derivatives used in food, nutraceuticals, cosmetics and personal care, and alginate production for industrial hydrocolloids.
Scope of the Study
The study quantifies the Global Ascophyllum Nodosum Extract Market by value in USD Million for the historic years 2022, 2023 and 2024, the base year 2025 and the forecast years 2026–2032. Compound annual growth rates are presented for the period 2026–2032. The scope covers the segmentations, regions and countries listed below.
Research Objectives
To estimate the size of the global Ascophyllum nodosum extract market for 2022–2025 and forecast it for 2026–2032 in value terms (USD Million).
To analyse the market by physical form, crop type and application method, and to identify the largest and fastest-growing segments.
To assess the market across North America, Europe, Asia Pacific, Latin America and Middle East & Africa and their constituent countries.
To examine the drivers, restraints, opportunities, trends and challenges shaping demand for Ascophyllum nodosum extracts in agriculture.
To evaluate the seaweed supply chain, from wild harvesting and raw-material licensing through extraction, formulation and distribution.
To review the regulatory frameworks governing plant biostimulants and seaweed harvesting in the major producing and consuming regions.
To profile the competitive environment, including the positioning of leading suppliers and key developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process designed to produce a consistent, verifiable estimate of market size and growth. The process comprises:
Market definition and scoping: fixing the product boundaries, segmentation, geographic coverage and timeline.
Secondary research: building a fact base on supply, demand, regulation, pricing and competitors.
Primary research: validating assumptions and filling information gaps through discussions with industry participants.
Market sizing: estimating the base-year market using top-down and bottom-up approaches, reconciled through data triangulation.
Forecasting: projecting the market to 2032 on the basis of demand, supply and regulatory factors.
Quality review: checking consistency across segments, regions and countries before finalising the dataset and report.
Secondary Research
Secondary research covered the following source types, selected for their relevance to seaweed-based plant biostimulants:
Industry associations: the European Biostimulants Industry Council (EBIC), the Biological Products Industry Alliance (BPIA) in the United States, the Biological Agri Solutions Association of India (BASAI), and national fertiliser and crop-protection associations.
Government and regulatory bodies: the European Commission and EUR-Lex (Regulation (EU) 2019/1009), the US Environmental Protection Agency, the Canadian Food Inspection Agency, Fisheries and Oceans Canada, provincial and state seaweed-management authorities in Nova Scotia and Maine, Ireland's Maritime Area Regulatory Authority, India's Department of Agriculture & Farmers Welfare, Brazil's Ministry of Agriculture and Livestock, and FAO fisheries and aquaculture statistics.
Trade statistics: international trade data for seaweeds and other algae not fit for human consumption (HS 1212.29) and for fertilisers of vegetable origin (HS 3101).
Company information: annual reports, investor presentations, press releases, product labels and technical data sheets of seaweed processors, agrochemical companies and fertiliser producers.
Trade and scientific literature: agricultural trade journals, peer-reviewed journals on applied phycology and plant science, patent databases and conference proceedings on biostimulants.
Paid databases: subscription company, trade and agricultural statistics databases used to cross-check revenue, shipment and crop-area data.
Primary Research
Primary research was conducted through in-depth interviews with participants on both the supply and demand sides. The objectives were to validate secondary findings, refine segment splits, understand pricing and purchasing behaviour, and gauge the outlook for growth.
Supply side: seaweed harvesting and processing companies, extract manufacturers, biostimulant formulators, fertiliser and agrochemical companies, and contract manufacturers.
Demand side: distributors and agro-dealers, crop advisers and agronomists, commercial growers of horticultural and row crops, turf and golf-course managers, and greenhouse operators.
Independent experts: academic researchers in phycology and plant physiology, regulatory consultants and industry association representatives.
Market Size Estimation
Top-down approach: The overall plant biostimulant market was used as a starting point and the share attributable to seaweed extracts, and within it to Ascophyllum nodosum, was estimated for each region using company disclosures, trade data and expert inputs. Regional totals were then split by country, physical form, crop type and application method.
Bottom-up approach: Supply-side estimates were built from harvesting and extraction volumes of the leading producers and converted to value using average realised prices for liquid and dry products. Demand-side estimates were built from treated crop area, application rates and adoption rates by crop group and country.
Data triangulation: Results from the top-down and bottom-up approaches were compared and reconciled. Where differences arose, assumptions were revisited using primary interviews until segment, regional and country estimates were consistent with each other and with the global total.
Forecasting Methodology
The forecast was developed by projecting base-year values for each country and segment using growth rates derived from the following factors:
Crop area and production trends for horticultural, cereal and grain, and turf and ornamental crops.
Adoption of biostimulants by crop and country, including the effect of new registrations and regulatory frameworks.
Raw-material availability, harvesting regulation and extraction capacity additions.
Pricing trends for liquid and dry extracts and for competing inputs.
Macroeconomic conditions, agricultural commodity prices and farm incomes.
Climate-related demand for abiotic-stress management products.
Growth rates were applied year by year, and the results were reviewed against historic growth and expert expectations to ensure that segment and regional trajectories remain internally consistent.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency and unit: USD Million
Assumptions and Limitations
Market values are expressed in nominal US dollars; values are converted from local currencies at average annual exchange rates, and exchange-rate movements are not forecast.
Values reflect the extract and Ascophyllum-based formulated products at the manufacturer and first-seller level.
No major disruption to wild Ascophyllum nodosum harvesting is assumed beyond existing regulatory limits and licensing processes.
Pending legislation, such as the proposed US Plant Biostimulant Act, is assumed to progress gradually and is not assumed to cause a step change in demand within the forecast period.
Many market participants are privately held and do not disclose revenue by product line; estimates for these companies rely on triangulation and expert judgement.
Blended products containing several seaweed species or other biostimulant ingredients are attributed to this market only where Ascophyllum nodosum is a declared and principal component.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Ascophyllum nodosum extract market is moderately consolidated at the upstream stage and fragmented downstream. Control of licensed harvesting areas and extraction capacity is concentrated among a small group of vertically integrated companies based in Atlantic Canada, Ireland, Norway and France. Downstream, a large number of formulators, fertiliser companies and distributors sell Ascophyllum-based products under their own brands, often using extract bought from integrated producers.
Competition takes place on several fronts. Secure raw material is the foundation of competitive advantage, as new harvesting licences are difficult to obtain. Proprietary extraction processes, such as cold-process, enzymatic and patented high-concentration methods, are used to differentiate products and support specific claims. Registered efficacy claims under the EU Fertilising Products Regulation and other frameworks are becoming a key marketing tool. Finally, access to growers through large distribution networks has prompted alliances between specialist seaweed producers and global agrochemical companies, as well as acquisitions of biostimulant businesses by larger groups.
Key Player Positioning
The leading companies have been grouped into leaders, challengers and niche players on the basis of their raw-material access, product portfolio, geographic reach and strategic activity in the Ascophyllum nodosum extract market.
Leaders
Acadian Plant Health (Acadian Seaplants Ltd): Founded in 1981 and family-owned, Acadian is the largest independent company in the market and works only with Ascophyllum nodosum. It harvests in Nova Scotia, New Brunswick, Maine, Ireland (through Arramara) and Scotland (through Uist Asco), and sells in more than 80 countries. Its strategy combines vertical integration with science-backed claims, notably its Abiotic Stress Management portfolio launched in 2025, and wider distribution through partnerships with BASF and Koppert.
Syngenta Biologicals (Valagro and Algea): Syngenta acquired Valagro in 2020, and with it Algea, a Norwegian company that harvests Ascophyllum year-round and processes it at Brønnøysund and Kristiansund. Syngenta Group reported sales of USD 28.4 billion in 2025. The company combines integrated Arctic raw-material supply with Valagro's formulation expertise and Syngenta's global distribution, and is expanding biological manufacturing capacity, including a new plant in South Carolina.
UPL Ltd (Laboratoires Goëmar): UPL's seaweed business is based at Laboratoires Goëmar in Saint-Malo, France, which uses hand-harvested North Atlantic Ascophyllum and patented extraction platforms such as GoActiv and Hycoxa. UPL reported revenue of INR 51,839 crore for FY2026. Its seaweed products are sold through the company's Natural Plant Protection biosolutions unit and global crop-protection network.
Challengers
Rovensa Next: The biosolutions unit of Rovensa, owned mainly by Partners Group and Bridgepoint, was formed in 2023 and includes Tradecorp and Oilean Glas Teoranta (OGT), which processes Irish Ascophyllum through a cold, low-temperature extraction process. Its Phylgreen range received a CE mark under Regulation (EU) 2019/1009 in September 2024.
Yara International: The world's largest nitrogen fertiliser producer reported revenue of USD 15.7 billion in 2025. Its YaraAmplix biostimulant range, launched in November 2023, includes Ascophyllum-based products combined with micronutrients and other ingredients, sold through Yara's crop-nutrition and agronomy channels.
Huber AgroSolutions: A business of the family-owned J.M. Huber Corporation, it includes Miller Chemical & Fertilizer and the Biolchim Group, acquired in November 2022. Its Millerplex product contains fresh Ascophyllum nodosum extract, and the group's wide specialty-nutrition portfolio and global plant network give it broad market access.
Niche Players
Brandon Bioscience (Ireland) specialises in claim-specific Ascophyllum extracts based on its PSI platform, including PSI362 for nitrogen-use efficiency, which is used as a coating on fertilisers. BioAtlantis (Ireland) produces concentrated seaweed extracts such as the SuperFifty range and is seeking additional harvesting rights in Clew Bay. North American Kelp (Maine) is a vertically integrated supplier of Ascophyllum liquids, powders and meal, including white-label supply. Kelpinor (Norway) is a start-up whose kelpAGRI-Asco product is CE-marked under the EU regulation and which is adding cultivated seaweed to its portfolio. Seasol International (Australia) is a family-owned company whose seaweed products, made from a blend of Durvillaea and Ascophyllum, are focused on Australian home-garden and horticultural markets.
Competitor Dashboard
The dashboard rates each profiled company on four qualitative parameters on a scale of Low, Medium, High and Very High, with respect to its activities in the Ascophyllum nodosum extract market.
Threat of New Entrants: Medium
Formulating and marketing seaweed-based products requires modest capital, and distributors can source extract in bulk.
Access to licensed Ascophyllum harvesting areas is limited and new licences face long approval processes and local opposition, creating a high barrier to integrated entry.
Claim-based registration under the EU regulation and in India requires efficacy data, which raises the cost of entry.
Bargaining Power of Suppliers: High
Raw material is geographically concentrated in a few North Atlantic coastlines and controlled by a limited number of licensed harvesters and integrated processors.
Biomass caps and harvest regulations restrict supply growth, supporting raw-material prices.
Formulators that lack their own harvest rights depend on integrated competitors or a small pool of independent processors.
Bargaining Power of Buyers: Medium
Growers are fragmented, but large distributors, agrochemical companies and fertiliser blenders buy significant volumes and can negotiate on price.
Buyers can switch to other seaweed species or biostimulant categories, particularly for price-sensitive crops.
Brand reputation, trial evidence and registered claims reduce switching for premium products.
Threat of Substitutes: Medium
Extracts of Ecklonia, Kappaphycus, Sargassum and Laminaria, as well as humic substances, protein hydrolysates and microbial biostimulants, address similar grower needs.
The extensive research base and trial evidence for Ascophyllum nodosum differentiate it from many substitutes.
Integrated programmes increasingly combine Ascophyllum extracts with other biostimulants rather than replacing them outright.
Intensity of Competitive Rivalry: High
Several large, well-funded groups (Syngenta, UPL, Rovensa, Yara and Huber) compete with the specialist market leader, Acadian Plant Health, and with numerous regional formulators.
Competition is intensifying around abiotic-stress and nutrient-use-efficiency claims and around distribution access.
Private-label and bulk supply create price competition, especially in powders and flakes.
Threat of new entrants: Medium; Low formulation barriers offset by restricted access to harvest licences and registration costs.
Bargaining power of suppliers: High; Concentrated, regulated raw-material supply held by a few integrated players.
Bargaining power of buyers: Medium; Large distributors and agrochemical partners negotiate; differentiation limits switching.
Threat of substitutes: Medium; Other seaweeds and biostimulant categories compete; strong evidence base for Ascophyllum.
Competitive rivalry: High; Major agrochemical groups and specialists compete on claims, supply and distribution.
Market estimates by geography (2032)
InsightEurope leads with $114.96M by 2032, while Asia Pacific is projected to grow fastest at a 11.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $26.65M | $41.34M | $63.63M | 9.1% | 19% |
| Europe | $49.77M | $75.98M | $114.96M | 8.7% | 35% |
| Asia Pacific | $27.54M | $47.36M | $80.49M | 11.3% | 24% |
| Latin America | $20.47M | $33.97M | $55.92M | 10.6% | 17% |
| Middle East & Africa | $6.47M | $10.54M | $17.07M | 10.2% | 5% |
| Total | $130.89M | $209.19M | $332.07M | 9.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$332.07M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Liquid | $225.15M | 10.4% | 68% |
| Powder & Flakes | $106.93M | 8.5% | 32% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Ascophyllum Nodosum Extract Market covering market dynamics, competitive landscape, and strategic outlook.
The Ascophyllum Nodosum Extract Market market is projected to reach $332.07M by 2032, growing at 9.8% CAGR. The Liquid segment holds the largest share.
Demand for Ascophyllum nodosum extracts is shaped by the interaction of agronomic need, regulation and raw-material supply. On the demand side, growers are adopting biostimulants to protect yield and quality against weather extremes and to obtain more value from fertiliser inputs. On the regulatory side, the creation of dedicated biostimulant categories in the European Union and India, and pending legislation in the United States, is improving market access and buyer confidence. On the supply side, the dependence on a slow-growing, wild-harvested seaweed that is subject to licensing and biomass limits constrains how quickly output can expand. This chapter assesses these forces through a growth factor analysis and a review of drivers, restraints, opportunities, trends and challenges.
Market Growth Factor Analysis
The table below rates five macro factors and five micro factors by the type of impact they exert on the market and by the strength of that impact over three forecast sub-periods. The impact scores are analyst assessments on a scale of 1 to 10, where 10 denotes the strongest influence on market growth; they are based on secondary research and industry interviews and reflect the expected relative importance of each factor rather than a statistical measurement.
Formal Regulatory Recognition of Plant Biostimulants
The establishment of dedicated legal categories for plant biostimulants has been one of the most important developments for the market. In the European Union, Regulation (EU) 2019/1009 on fertilising products has applied since 16 July 2022 and created a product function category for plant biostimulants. Products that pass conformity assessment can carry the CE mark and be sold across all EU member states on the basis of defined claims, including nutrient-use efficiency, tolerance to abiotic stress and crop-quality traits. Ascophyllum-based products have already used this route: Rovensa Next obtained a CE mark for its Phylgreen range in September 2024, and Acadian Plant Health received a CE mark for its Ready for Stress product in August 2026. In India, biostimulants were brought under the Fertiliser (Control) Order, 1985 through Schedule VI in February 2021, and the 2024 revision of the procedure exempted Ascophyllum nodosum extracts, along with other listed seaweeds, from toxicology data requirements. In the United States, the proposed Plant Biostimulant Act would create a federal definition of plant biostimulants. Clear rules reduce regulatory uncertainty for suppliers, support the use of efficacy claims on labels and raise buyer confidence in established products.
Rising Exposure of Crops to Abiotic Stress
Growers face more frequent drought, heatwaves, irregular rainfall and soil salinisation, which reduce yield and quality even where nutrition and crop protection are well managed. Ascophyllum nodosum extracts are among the most extensively researched biostimulants for mitigating abiotic stress; published studies have linked their use to improved water relations, antioxidant activity and root growth under stress conditions. Suppliers are responding with products and portfolios built specifically around stress management. Acadian Plant Health launched its Abiotic Stress Management portfolio in February 2025, and UPL introduced biostimulants based on its patented Hycoxa Ascophyllum extraction technology in December 2025, targeting abiotic-stress tolerance and nitrogen uptake. Because stress events are difficult to predict, many growers now apply extracts preventively at sensitive crop stages such as flowering and fruit set, which supports recurring demand. This driver is expected to strengthen over the forecast period as climate variability increases and as more products carry registered abiotic-stress claims.
Focus on Nutrient-Use Efficiency and Lower Synthetic Inputs
Agricultural policy in several major markets is pushing growers to obtain the same or higher yields with fewer synthetic inputs. The European Union's Farm to Fork Strategy aims to reduce nutrient losses by at least 50% and fertiliser use by at least 20% by 2030. Japan's Strategy for Sustainable Food Systems (MIDORI) sets long-term targets for reducing chemical fertiliser use, and China has pursued policies to curb fertiliser overuse since its 2015 action plan for zero growth in fertiliser use. The sharp rise in fertiliser prices in 2022 further highlighted the economic value of getting more from each unit of nutrient applied. Ascophyllum nodosum extracts are increasingly positioned as nutrient-use-efficiency tools, either as stand-alone treatments or as coatings on granular fertilisers. For example, Brandon Bioscience's PSI362 extract is used as a coating on NPK fertilisers sold in Ireland. This positioning broadens the market beyond specialty horticulture into mainstream fertiliser programmes.
Growth of High-Value Horticulture and Organic Production
Fruits and vegetables account for 50.0% of global demand for Ascophyllum nodosum extracts in 2025, and expansion of high-value horticulture remains a core driver. Export-oriented producers of berries, avocados, citrus, grapes and greenhouse vegetables in regions such as Mexico, Spain, Chile, Peru and Morocco must meet strict buyer specifications on fruit size, colour, shelf life and pesticide residues. Biostimulants help growers address these quality parameters without adding to residue profiles. Protected cultivation and fertigation systems, which are widespread in horticulture, also suit liquid extracts. In addition, many Ascophyllum extracts are accepted as inputs in organic production: the EU organic rules authorise seaweed products as fertilisers, and in the United States several products are listed for organic use. As certified organic area and protected cultivation expand, the base of growers using seaweed extracts as a routine input continues to widen.
Seed Treatment and Fertiliser-Coating Applications
Seed treatment is the smallest application method at USD 17.35 Million in 2025 but the fastest growing, with a CAGR of 12.22% to 2032. Seed treatments and fertiliser coatings deliver extract at very low rates per hectare, fit into existing seed and fertiliser supply chains and require no extra field pass. These formats make Ascophyllum extracts economical on broadacre crops and allow seed companies and fertiliser producers to add differentiated value to their products. Partnerships between extract producers and seed or fertiliser companies represent a significant growth avenue.
Penetration of Broadacre Crops and Emerging Markets
Cereals & grains are the fastest-growing crop segment (CAGR 10.96%), and Asia Pacific is the fastest-growing region (CAGR 11.22%). India (CAGR 13.51%), China (CAGR 12.21%) and Brazil (CAGR 11.12%) combine large crop areas with low current adoption of biostimulants. Clearer registration pathways, such as India's Schedule VI and Brazil's bioinputs framework, and the expansion of global distribution networks into these countries create room for strong volume growth.
Sustainable Supply and Advanced Extraction
Companies that can expand supply sustainably have a clear advantage. Opportunities include certified harvest-management plans, investment in processing efficiency, cold and enzymatic extraction processes that preserve bioactive compounds and allow higher-value claims, and the use of cultivated seaweed to complement wild Ascophyllum. Traceable, sustainably harvested supply is becoming a selling point for food retailers and growers who report on their environmental footprint.
Constrained and Regulated Raw-Material Supply
Ascophyllum nodosum is almost entirely harvested from wild intertidal stands, grows slowly and takes several years to recover after cutting. Harvesting is therefore regulated through leases, cutting-height rules and biomass caps. In Nova Scotia, commercial harvesting requires leases and regulations prescribe minimum cutting heights; in Maine, harvest plans for Cobscook Bay limit removal to 17% of harvestable biomass, and a 2019 ruling by the Maine Supreme Judicial Court found that intertidal rockweed belongs to the upland owner, requiring landowner permission to harvest. In Ireland, licence applications to harvest Ascophyllum in Conamara and in Clew Bay were contested by local rights holders in 2026. These constraints limit how quickly supply can respond to demand, concentrate raw material among a few licensed companies and raise costs for new entrants.
Variable Efficacy and Product Quality
Field responses to seaweed extracts vary with crop, growth stage, weather, soil conditions and the extraction process used, which makes it difficult for growers to predict a return on investment. Product composition also varies between suppliers and production batches, and markets have historically included products of uncertain quality. In India, 9,352 provisional biostimulant registrations were cancelled from 17 June 2025 after the provisional registration regime ended, illustrating the scale of unverified products that had entered the market. Such variability fuels grower scepticism and slows adoption among large-scale row-crop farmers, who typically require consistent, multi-season trial evidence before adding a new input.
Regulatory Fragmentation and Registration Costs
Although regulation is improving, requirements still differ widely between jurisdictions. In the United States there is no federal definition of a plant biostimulant, so products are registered state by state and must avoid claims that would trigger regulation as plant regulators under federal pesticide law. Great Britain no longer follows the EU CE-marking route, and countries in Latin America, Asia and Africa apply their own fertiliser and bioinput rules. Generating efficacy data for claim-based registration is costly and time-consuming, which favours large suppliers and can delay market entry for smaller producers.
Challenge: Social Licence and Sustainability of Harvesting
Coastal communities, traditional harvesters and conservation groups are paying closer attention to the ecological role of rockweed beds as habitat. Licensing processes in Ireland, private-property rulings in Maine and lease management in Nova Scotia show that access to raw material depends increasingly on demonstrating sustainable practices and community benefit. Delays or restrictions in licensing could limit supply growth for individual companies.
Challenge: Competition from Substitutes
Ascophyllum extracts compete with extracts of other seaweeds, such as Ecklonia maxima, Kappaphycus alvarezii and Sargassum species, which are often cheaper and locally available in Asia and Africa. They also compete with other biostimulant categories, including humic and fulvic substances, protein hydrolysates and microbial products. Price competition is strongest in powder and flake products and in price-sensitive markets, which puts pressure on margins and requires Ascophyllum suppliers to demonstrate a clear performance advantage.
Trend: Shift Toward Claim-Specific, Science-Backed Products
Suppliers are moving from general "plant tonic" positioning toward products defined by a specific function, such as tolerance to drought, heat or salinity, nutrient-use efficiency or fruit set, and supported by multi-year field trials and patents. Rovensa Next supported its Phylgreen CE mark with more than 70 trials conducted since 2015, and Brandon Bioscience markets separate extracts for nitrogen-use efficiency, pod-shatter reduction and heat, salt and water stress. This trend aligns product development with the claim-based structure of the EU regulation.
Trend: Distribution Alliances and Consolidation
Large agrochemical and fertiliser companies are building biological portfolios through acquisitions and distribution agreements. Acadian Plant Health entered distribution partnerships with Koppert in the United States in April 2024 and with BASF Agricultural Solutions for several European countries and China in October 2024. Syngenta launched its Syngenta Biologicals brand in April 2024 and opened a biostimulant manufacturing plant in Orangeburg, South Carolina, in 2025, while J.M. Huber completed its acquisition of the Biolchim Group in November 2022. These moves are expanding the reach of Ascophyllum-based products and raising the importance of scale.
The value chain for Ascophyllum nodosum extracts runs from wild harvesting along North Atlantic coastlines to growers worldwide. The leading companies are vertically integrated across harvesting, processing and branded product sales, while many others operate at only one or two stages.
Raw materials and inputs: Raw-material access is the most strategic stage of the chain. Supply comes mainly from Atlantic Canada, Maine, Ireland, Scotland, Norway, Iceland and France. Companies with long-term harvest rights, such as Acadian Seaplants and Algea, hold a structural advantage, and new licences are hard to obtain.
Manufacturing: Harvested seaweed is processed into extract through alkaline, neutral, cold or enzymatic methods. The process determines the profile of bioactive compounds and is protected by patents and know-how. Liquid concentrates are standardised for solids content and pH, while powders and flakes are produced by drying and are favoured for long-distance shipment.
Distribution and channels: Branded products reach growers through distributors, agro-dealers and cooperatives, and increasingly through the networks of large agrochemical and fertiliser companies that either own extraction capacity or hold distribution rights. Extracts are also supplied in bulk to formulators who incorporate them into blended products.
End users: Fruit and vegetable growers are the largest user group, followed by cereal and grain producers, turf and ornamental managers and growers of other crops. Purchasing decisions are strongly influenced by agronomists and distributor advice.
Ascophyllum nodosum extracts are affected by two sets of rules: those governing the sale of fertilising products and biostimulants, and those governing the harvesting of wild seaweed. The key regulations by major region are summarised below.
North America
United States: Products are registered as fertilisers or soil amendments under state fertiliser laws. Products making plant-growth claims may fall under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) as plant regulators; the US Environmental Protection Agency has issued draft guidance on plant regulator claims, including plant biostimulants. The proposed Plant Biostimulant Act of 2025 (H.R. 3783 and S. 1907) would establish a federal definition and was carried forward in farm bill legislation during 2026. Under the USDA National Organic Program, aquatic plant extracts are permitted subject to limits on the extraction process (7 CFR 205.601).
Maine: Rockweed harvesting is subject to harvest plans under 12 M.R.S. §6803-C for Cobscook Bay, with a cap of 17% of harvestable biomass per sector.
Canada: Fertilisers and supplements are regulated under the Fertilizers Act and Fertilizers Regulations administered by the Canadian Food Inspection Agency. In Nova Scotia, rockweed harvesting is governed by the Rockweed Harvesting Regulations under the Fisheries and Coastal Resources Act, with leases and cutting-height requirements.
Europe
European Union: Regulation (EU) 2019/1009 (Fertilising Products Regulation), applicable since 16 July 2022, defines plant biostimulants as a product function category with CE marking and claim-based conformity assessment. Supporting European standards for plant biostimulants have been developed by CEN Technical Committee 455.
EU organic production: Regulation (EU) 2018/848 and Implementing Regulation (EU) 2021/1165 set the list of fertilisers authorised in organic production, which includes seaweeds and seaweed products.
Ireland: Seaweed harvesting licences are processed by the Maritime Area Regulatory Authority under the Maritime Area Planning Act 2021.
United Kingdom: Great Britain applies domestic fertiliser legislation rather than the EU CE-marking route. Wild seaweed harvesting in Scotland falls within marine licensing under the Marine (Scotland) Act 2010.
Asia Pacific
India: Biostimulants are regulated under Schedule VI of the Fertiliser (Control) Order, 1985, introduced by notification S.O. 882(E) of 23 February 2021 and revised by S.O. 1963(E) of 8 May 2024. Provisional registrations ended in 2025, and only products listed in Schedule VI may be sold.
China: Fertiliser products, including those containing seaweed extracts, are subject to registration with the Ministry of Agriculture and Rural Affairs.
Japan: Fertilisers are regulated by the Ministry of Agriculture, Forestry and Fisheries, whose MIDORI strategy promotes reductions in chemical fertiliser use.
Latin America
Brazil: Fertilisers, biofertilisers and related inputs are regulated by the Ministry of Agriculture and Livestock under Law No. 6,894/1980 and Decree No. 4,954/2004. Law No. 15,070/2024 established a dedicated legal framework for bioinputs.
Argentina: Fertiliser and amendment products are registered with the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
South Africa: Fertilisers are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947).
Gulf Cooperation Council countries: Fertilisers and soil conditioners require national registration with the relevant ministries responsible for agriculture and environment.
The table below lists key launches, acquisitions, partnerships, expansions and other developments by the profiled companies since 2022.
Feb 2022: Brandon Bioscience; Partnership; Target Fertilisers launched its "Terra" fertiliser range in Ireland, coated with Brandon Bioscience's PSI362 Ascophyllum extract.
Sep 2022: Acadian Plant Health; Expansion; Received a repayable contribution of CAD 2.0 million from the Atlantic Canada Opportunities Agency to purchase automated processing equipment and expand its Cornwallis, Nova Scotia facility.
Nov 2022: Huber AgroSolutions; Acquisition; J.M. Huber Corporation completed the acquisition of the Biolchim Group, announced in August 2022.
Feb 2023: Rovensa Next; Business launch; Rovensa launched Rovensa Next, its biosolutions unit bringing together ten companies, including Tradecorp and OGT.
Nov 2023: Yara International; Product launch; Launched the YaraAmplix biostimulant range, including Ascophyllum-based products.
Apr 2024: Acadian Plant Health; Partnership; Koppert USA became a distributor of Acadian and Acadian Organic products in the United States.
Apr 2024: Syngenta Biologicals; Brand launch; Syngenta launched the Syngenta Biologicals brand, bringing together its biological businesses, including Valagro.
Sep 2024: Rovensa Next; Regulatory approval; The Phylgreen Ascophyllum range received a CE mark under Regulation (EU) 2019/1009, enabling sale across all 27 EU member states.
Oct 2024: Acadian Plant Health; Partnership; Signed a distribution partnership with BASF Agricultural Solutions covering several European countries and China.
Dec 2024: Syngenta Biologicals; Acquisition; Acquired Intrinsyx Bio, a US company developing nutrient-use-efficiency biologicals.
Jan 2025: Acadian Plant Health; Partnership; Extended its partnership with Koppert to Europe, the Middle East and Africa, starting with France.
Feb 2025: Acadian Plant Health; Product launch; Launched its Abiotic Stress Management portfolio.
2025: Syngenta Biologicals; Expansion; Opened a biostimulant manufacturing plant in Orangeburg, South Carolina, with capacity of 16,000 tonnes per year.
Nov 2025: Acadian Plant Health; Expansion; Introduced its "One Acadian" operating model across 13 Latin American countries.
Dec 2025: UPL Ltd; Product launch; Launched seaweed biostimulants based on its patented Hycoxa Ascophyllum extraction technology, targeting abiotic-stress tolerance and nitrogen uptake.
Feb 2026: Acadian Plant Health; Raw-material supply; Its Irish subsidiary Arramara renewed applications to Ireland's Maritime Area Regulatory Authority for licences to harvest seaweed in Conamara.
Feb 2026: Kelpinor; Expansion; Completed its first commercial export of a cultivated-seaweed biostimulant, to Germany.
Mar 2026: BioAtlantis; Raw-material supply; Pursued its application to Ireland's Maritime Area Regulatory Authority to harvest Ascophyllum nodosum in Clew Bay, Co. Mayo.
Aug 2026: Acadian Plant Health; Regulatory approval; Its Ready for Stress product received a CE mark under the EU Fertilising Products Regulation, its first EU-registered abiotic-stress product.
Political
Government food-security and sustainable-agriculture strategies, such as the EU Farm to Fork Strategy and Japan's MIDORI strategy, favour inputs that reduce dependence on synthetic fertilisers.
Trade policy and tariffs affect cross-border flows of seaweed raw material and extract from North Atlantic producers to Asia and Latin America.
Coastal resource management decisions by provincial, state and national authorities determine access to harvesting areas.
Economic
Fertiliser price volatility, such as the 2022 price spike, increases interest in nutrient-use-efficiency products.
Farm incomes and crop prices influence spending on discretionary inputs such as biostimulants, particularly in row crops.
Currency movements affect the competitiveness of exports from Canada, Europe and Norway.
Social
Consumer demand for residue-free and sustainably produced food encourages retailers and growers to adopt biological inputs.
Coastal communities and traditional harvesters increasingly influence licensing outcomes and expect a share of economic benefits.
Grower awareness and trust depend on advisor recommendations and visible field results.
Technological
Advances in extraction, including cold, enzymatic and patented processes, enable more consistent and higher-value products.
Omics-based research and controlled trials are improving understanding of modes of action and supporting registered claims.
Seed-treatment and fertiliser-coating technologies allow low-rate delivery on broadacre crops.
Environmental
Climate change increases the frequency of drought, heat and salinity stress, raising demand for stress-mitigation products.
Sustainable harvest management is required to protect rockweed habitats and maintain long-term supply.
Ocean warming may affect the distribution and productivity of Ascophyllum stands over the long term.
Legal
Claim-based registration under Regulation (EU) 2019/1009 and India's Schedule VI defines what suppliers may state on labels.
The absence of a federal biostimulant definition in the United States leaves products subject to state-by-state rules.
Court rulings and harvesting regulations, such as the 2019 Maine ruling on intertidal rockweed ownership, shape harvesting rights.
Profiles of 109 companies operating in the Ascophyllum Nodosum Extract Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
4 interactive charts drawn from the Ascophyllum Nodosum Extract Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Ascophyllum Nodosum Extract Market By Application Method
Global Ascophyllum Nodosum Extract Market By Crop Type
Global Ascophyllum Nodosum Extract Market By Physical Form
Global Ascophyllum Nodosum Extract Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)